​Discontinued Laboratory Codes Related to COVID-19​, CR 117890

On May 10, 2023, CMS updated the Laboratories: CMS Flexibilities to Fight COVID-19 document found on the CMS Coronavirus waivers and flexibilities web page. The updated document reflects that, effective May 11, 2023, the following laboratory codes related to COVID-19 lab analysis and specimen collection have been terminated and may no longer be billed.     

Code  

Description  

Effective Date  

End Date  

U0003  

Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies as described by CMS-2020-01-R.  

04/14/20  

05/11/23  

U0004  

2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies as described by CMS-2020-01-R.  

04/14/20  

05/11/23  

U0005  

Infectious agent detection by nucleic acid (DNA or RNA); Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, CDC or non-CDC, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either HCPCS code U0003 or U0004) as described by CMS-2020-01-R2  

04/14/20  

05/11/23  

G2023  

Specimen collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), any specimen source  

03/01/20  

05/11/23  

G2024  

Specimen collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) from an individual in a SNF or by a laboratory on behalf of a HHA, any specimen source  

03/01/20  

05/11/23  

  

If you have questions related to these lab analysis and specimen collection codes, please contact your Provider Relations Specialist.